# Biolife4d

**Canonical:** https://apis.io/providers/biolife4d/  
**Website:** https://equityzen.com/company/biolife4d  
**APIs profiled:** 0

Biolife4d is a biotech company focusing on advanced 3D bioprinting technologies for tissue engineering and regenerative medicine. The firm aims to develop scalable, high‑resolution bioprinting solutions that enable the creation of functional human tissues for research, drug testing, and therapeutic applications. While still emerging, Biolife4d positions itself at the intersection of biotechnology and additive manufacturing, targeting collaborations with academic institutions and pharmaceutical partners to accelerate translational research.

## Kin Score — 3.1 / 100 (minimal)

Scored 2026-10-23 under rubric 0.25.0. Trend: flat (+0.0 from 3.1).

| Facet | Score |
|---|---|
| Discoverability | 44.6 |
| Contract Quality | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Horizontal (data, software, accessibility, platform)**: 5.9 (matched via fallback).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |
| Pagination Ratio | na |
| Operation Distinctiveness | na |

## Security (1)

- **Biolife4D Domain Security** — TLSv1.3 · DMARC

## Tags

Company, Biotechnology, 3D Printing, Tissue Engineering, Regenerative Medicine

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/biolife4d/). Scores are computed from the provider's own public artifacts under a published rubric.